Al-Razi Orthopedic Hospital, Kuwait, Kuwait.
Hull University Teaching Hospitals, Hull, UK.
J Orthop Surg Res. 2024 Jun 14;19(1):351. doi: 10.1186/s13018-024-04832-7.
Chronic osteomyelitis is a debilitating bone infection, characterized by a persistent infection over months to years, poses diagnostic and therapeutic challenges due to its insidious nature and potential for severe bone and soft tissue destruction. This systematic review and meta-analysis aims to review the literature on the treatment of chronic osteomyelitis in long bones and assess cure rates in single versus two-stage surgery.
Following the PRISMA guidelines and registered with PROSPERO (ID: CRD42021231237), this review included studies that reported on the management of chronic osteomyelitis in long bones using either a planned one-stage or two-stage surgical approach in adult patients. Databases searched included Medline, Embase, Web of Science, CINAHL, HMIC, and AMED, using keywords related to osteomyelitis, long bones, and surgical management. Eligibility criteria focused on adults with chronic osteomyelitis in long bones, with outcomes reported after a minimum follow-up of 12 months. The meta-analysis utilized the random-effects model to pool cure rates.
The analysis included 42 studies with a total of 1605 patients. The overall pooled cure rate was 91% (CI 95%) with no significant difference observed between single-stage and two-stage surgeries (X2 = 0.76, P > 0.05). Complications were reported in 26.6% of cases in single-stage procedures and 27.6% in two-stage procedures, with prolonged wound drainage noted as a common issue. Dead space management techniques varied across studies, with antibiotic-loaded calcium sulphate beads used in 30.4% of cases.
This meta-analysis reveals no significant difference in cure rates between single and two-stage surgical treatments for chronic osteomyelitis in long bones, supporting the efficacy of both approaches. The current treatment strategy should include a combination of debridement, dead space management using local and systematic antibiotics and soft tissue reconstruction if necessary.
慢性骨髓炎是一种使人虚弱的骨感染,其特征是持续感染数月至数年,由于其隐匿性和潜在的严重骨和软组织破坏,诊断和治疗具有挑战性。本系统评价和荟萃分析旨在回顾关于长骨慢性骨髓炎治疗的文献,并评估单阶段与双阶段手术的治愈率。
根据 PRISMA 指南,并在 PROSPERO(ID:CRD42021231237)上注册,本综述纳入了在成年患者中使用计划单阶段或双阶段手术方法治疗长骨慢性骨髓炎的研究。检索的数据库包括 Medline、Embase、Web of Science、CINAHL、HMIC 和 AMED,使用与骨髓炎、长骨和手术管理相关的关键词。纳入标准侧重于长骨慢性骨髓炎的成年患者,至少随访 12 个月后报告结局。荟萃分析采用随机效应模型来汇总治愈率。
分析纳入了 42 项研究,共计 1605 名患者。总体治愈率为 91%(95%CI),单阶段和双阶段手术之间未观察到显著差异(X2=0.76,P>0.05)。单阶段手术中报告了 26.6%的病例出现并发症,双阶段手术中报告了 27.6%的病例出现并发症,延长的伤口引流是一个常见问题。研究之间的死腔管理技术各不相同,30.4%的病例使用抗生素负载硫酸钙珠。
本荟萃分析显示,长骨慢性骨髓炎的单阶段和双阶段手术治疗的治愈率无显著差异,支持两种方法的疗效。目前的治疗策略应包括清创术,使用局部和系统抗生素管理死腔,如果必要,还应进行软组织重建。